首页> 外文OA文献 >1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
【2h】

1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.

机译:1-苯基亚磺酰基-3-(吡啶-3-基)萘-2-醇类:一类新型的有效和选择性醛固酮合酶抑制剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols and related compounds were synthesized and evaluated for inhibition of aldosterone synthase (CYP11B2), a potential target for cardiovascular diseases associated with elevated plasma aldosterone levels like congestive heart failure and myocardial fibrosis. Introduction of substituents at the phenylsulfinyl moiety and changes of the substitution pattern at the naphthalene core were examined. Potent compounds were further examined for selectivity versus other important steroidogenic CYP enzymes, i.e. the highly homologous 11β-hydroxylase (CYP11B1), CYP17 and CYP19. The most potent compound (IC50 = 14 nM) discovered was the meta-trifluoromethoxy derivative 11, which also exhibited excellent selectivity toward CYP11B1 (SF = 415), and showed no inhibition of CYP17 and CYP19.
机译:合成了1-苯基亚磺酰基-3-(吡啶-3-基)萘-2-醇和相关化合物,以抑制醛固酮合酶(CYP11B2)的抑制作用。醛固酮合酶是与血浆醛固酮水平升高(如充血性心力衰竭)相关的心血管疾病的潜在靶标和心肌纤维化。检查了在苯亚磺酰基部分上的取代基的引入以及在萘核心上的取代模式的变化。与其他重要的类固醇生成CYP酶(即高度同源的11β-羟化酶(CYP11B1),CYP17和CYP19)相比,进一步检查了强效化合物的选择性。发现的最有效的化合物(IC50 = 14 nM)是间三氟甲氧基衍生物11,它也对CYP11B1表现出优异的选择性(SF = 415),对CYP17和CYP19没有抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号